Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Tamara B. Harris, Luigi Ferrucci, Russell P. Tracy, M. Chiara Corti, Sholom Wacholder, Walter H. Ettinger, Harley Heimovitz, Harvey J. Cohen, Robert Wallace

Research output: Contribution to journalArticle

Abstract

PURPOSE: To investigate whether interleukin-6 and C-reactive protein levels predict all-cause and cause-specific mortality in a population-based sample of nondisabled older people. SUBJECTS AND METHODS: A sample of 1,293 healthy, nondisabled participants in the Iowa 65+ Rural Health Study was followed prospectively for a mean of 4.6 years. Plasma interleukin-6 and C- reactive protein levels were measured in specimens obtained from 1987 to 1989. RESULTS: Higher interleukin-6 levels were associated with a twofold greater risk of death [relative risk (RR) for the highest quartile (≥3.19 pg/mL) compared with the lowest quartile of 1.9 [95% confidence interval, CI, 1.2 to 3.1]). Higher C-reactive protein levels (≥ 2.78 mg/L) were also associated with increased risk (RR = 1.6; CI, 1.0 to 2.6). Subjects with elevation of both interleukin-6 and C-reactive protein levels were 2.6 times more likely (CI, 1.6 to 4.3) to die during follow-up than those with low levels of both measurements. Similar results were found for cardiovascular and noncardiovascular causes of death, as well as when subjects were stratified by sex, smoking status, and prior cardiovascular disease, and for both early (

Original languageEnglish (US)
Pages (from-to)506-512
Number of pages7
JournalAmerican Journal of Medicine
Volume106
Issue number5
DOIs
StatePublished - May 1999
Externally publishedYes

Fingerprint

C-Reactive Protein
Interleukin-6
Mortality
Rural Health
Cause of Death
Healthy Volunteers
Cardiovascular Diseases
Smoking
Confidence Intervals
Population

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., ... Wallace, R. (1999). Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. American Journal of Medicine, 106(5), 506-512. https://doi.org/10.1016/S0002-9343(99)00066-2

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. / Harris, Tamara B.; Ferrucci, Luigi; Tracy, Russell P.; Corti, M. Chiara; Wacholder, Sholom; Ettinger, Walter H.; Heimovitz, Harley; Cohen, Harvey J.; Wallace, Robert.

In: American Journal of Medicine, Vol. 106, No. 5, 05.1999, p. 506-512.

Research output: Contribution to journalArticle

Harris, TB, Ferrucci, L, Tracy, RP, Corti, MC, Wacholder, S, Ettinger, WH, Heimovitz, H, Cohen, HJ & Wallace, R 1999, 'Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly', American Journal of Medicine, vol. 106, no. 5, pp. 506-512. https://doi.org/10.1016/S0002-9343(99)00066-2
Harris, Tamara B. ; Ferrucci, Luigi ; Tracy, Russell P. ; Corti, M. Chiara ; Wacholder, Sholom ; Ettinger, Walter H. ; Heimovitz, Harley ; Cohen, Harvey J. ; Wallace, Robert. / Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. In: American Journal of Medicine. 1999 ; Vol. 106, No. 5. pp. 506-512.
@article{54d4aca7e02c417a83ad6ea278d1829f,
title = "Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly",
abstract = "PURPOSE: To investigate whether interleukin-6 and C-reactive protein levels predict all-cause and cause-specific mortality in a population-based sample of nondisabled older people. SUBJECTS AND METHODS: A sample of 1,293 healthy, nondisabled participants in the Iowa 65+ Rural Health Study was followed prospectively for a mean of 4.6 years. Plasma interleukin-6 and C- reactive protein levels were measured in specimens obtained from 1987 to 1989. RESULTS: Higher interleukin-6 levels were associated with a twofold greater risk of death [relative risk (RR) for the highest quartile (≥3.19 pg/mL) compared with the lowest quartile of 1.9 [95{\%} confidence interval, CI, 1.2 to 3.1]). Higher C-reactive protein levels (≥ 2.78 mg/L) were also associated with increased risk (RR = 1.6; CI, 1.0 to 2.6). Subjects with elevation of both interleukin-6 and C-reactive protein levels were 2.6 times more likely (CI, 1.6 to 4.3) to die during follow-up than those with low levels of both measurements. Similar results were found for cardiovascular and noncardiovascular causes of death, as well as when subjects were stratified by sex, smoking status, and prior cardiovascular disease, and for both early (",
author = "Harris, {Tamara B.} and Luigi Ferrucci and Tracy, {Russell P.} and Corti, {M. Chiara} and Sholom Wacholder and Ettinger, {Walter H.} and Harley Heimovitz and Cohen, {Harvey J.} and Robert Wallace",
year = "1999",
month = "5",
doi = "10.1016/S0002-9343(99)00066-2",
language = "English (US)",
volume = "106",
pages = "506--512",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

AU - Harris, Tamara B.

AU - Ferrucci, Luigi

AU - Tracy, Russell P.

AU - Corti, M. Chiara

AU - Wacholder, Sholom

AU - Ettinger, Walter H.

AU - Heimovitz, Harley

AU - Cohen, Harvey J.

AU - Wallace, Robert

PY - 1999/5

Y1 - 1999/5

N2 - PURPOSE: To investigate whether interleukin-6 and C-reactive protein levels predict all-cause and cause-specific mortality in a population-based sample of nondisabled older people. SUBJECTS AND METHODS: A sample of 1,293 healthy, nondisabled participants in the Iowa 65+ Rural Health Study was followed prospectively for a mean of 4.6 years. Plasma interleukin-6 and C- reactive protein levels were measured in specimens obtained from 1987 to 1989. RESULTS: Higher interleukin-6 levels were associated with a twofold greater risk of death [relative risk (RR) for the highest quartile (≥3.19 pg/mL) compared with the lowest quartile of 1.9 [95% confidence interval, CI, 1.2 to 3.1]). Higher C-reactive protein levels (≥ 2.78 mg/L) were also associated with increased risk (RR = 1.6; CI, 1.0 to 2.6). Subjects with elevation of both interleukin-6 and C-reactive protein levels were 2.6 times more likely (CI, 1.6 to 4.3) to die during follow-up than those with low levels of both measurements. Similar results were found for cardiovascular and noncardiovascular causes of death, as well as when subjects were stratified by sex, smoking status, and prior cardiovascular disease, and for both early (

AB - PURPOSE: To investigate whether interleukin-6 and C-reactive protein levels predict all-cause and cause-specific mortality in a population-based sample of nondisabled older people. SUBJECTS AND METHODS: A sample of 1,293 healthy, nondisabled participants in the Iowa 65+ Rural Health Study was followed prospectively for a mean of 4.6 years. Plasma interleukin-6 and C- reactive protein levels were measured in specimens obtained from 1987 to 1989. RESULTS: Higher interleukin-6 levels were associated with a twofold greater risk of death [relative risk (RR) for the highest quartile (≥3.19 pg/mL) compared with the lowest quartile of 1.9 [95% confidence interval, CI, 1.2 to 3.1]). Higher C-reactive protein levels (≥ 2.78 mg/L) were also associated with increased risk (RR = 1.6; CI, 1.0 to 2.6). Subjects with elevation of both interleukin-6 and C-reactive protein levels were 2.6 times more likely (CI, 1.6 to 4.3) to die during follow-up than those with low levels of both measurements. Similar results were found for cardiovascular and noncardiovascular causes of death, as well as when subjects were stratified by sex, smoking status, and prior cardiovascular disease, and for both early (

UR - http://www.scopus.com/inward/record.url?scp=0033134682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033134682&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(99)00066-2

DO - 10.1016/S0002-9343(99)00066-2

M3 - Article

VL - 106

SP - 506

EP - 512

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 5

ER -